View ICR - OIRA Conclusion



0910-0675 201703-0910-008
Historical Active 201401-0910-002
HHS/FDA CDER
Guidance for Industry (GFI): Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products
Extension without change of a currently approved collection   No
Regular
Approved without change 05/18/2017
03/15/2017
  Inventory as of this Action Requested Previously Approved
05/31/2020 36 Months From Approved 05/31/2017
72 0 72
35,032 0 35,032
0 0 0